BioCentury | Jul 16, 2019
Financial News

How ophthalmic play Trefoil plans to deploy $28M series A

...IND in early 2020 and complete a Phase IIa proof-of-concept trial of its lead product, TTHX1114...
...sciences at Florida State. Corneal transplantation is the only treatment available for endothelial corneal diseases. TTHX1114...
...of TTHX1114 to treat corneal ulcerative conditions and submit an IND in 2021 for topical TTHX1114...
Items per page:
1 - 1 of 1